Editt: Third quarter report 2024

SZSIOct 27 12:00 ET · Announcements

Aidite (301580.SZ): The net income in the first three quarters was 0.111 billion yuan, a year-on-year increase of 12.71%.

Adtech (301580.SZ) announced on October 27th that it achieved revenue of 0.641 billion yuan in the first three quarters of 2024, a year-on-year growth of 14.09%; net income attributable to the listed company's shareholders was 0.111 billion yuan, a year-on-year growth of 12.71%, with basic earnings per share of 1.75 yuan.

Gelonghui FinanceOct 27 04:29 ET

EdiTech (301580.SZ) released its performance for the first three quarters, with a net income of 0.111 billion yuan, a year-on-year increase of 12.71%.

Edith (301580.SZ) released the third quarter report for 2024, with revenue for the first three quarters of the company at 6.4...

Zhitong FinanceOct 27 03:43 ET

Aidite (301580.SZ): As of the end of 2023, the proportion of the R&D team reached 14.64%, and R&D innovation investment has been increasing year by year.

Gelonghui, Oct. 14th - Edith (301580.SZ) stated on the investor interaction platform that the company has been shortlisted for the sixth batch of national specialized, special, and new "little giant" enterprise public announcement list, and was publicly announced in early September 2024. The company focuses on casting specialty, enhancing industrial matching, and winning the market through innovation. By the end of 2023, the research and development team accounted for 14.64%, with annual increases in research and development innovation investment. After more than 10 years of technological accumulation and product iteration, starting from 2021, the company has successively won the first prize of the Beijing Science and Technology Award, the Geneva Invention Gold Award, and other honors, and has obtained the national key research and development program "diagnosis".

Gelonghui FinanceOct 14 04:25 ET

Individual Investors Who Hold 35% of Aidite (Qinhuangdao) Technology Co., Ltd. (SZSE:301580) Gained 27%, Insiders Profited as Well

Simply Wall StOct 3 02:43 ET

Admate (301580.SZ): zirconia material is currently the preferred material for clinical oral restoration due to its excellent performance.

On September 29th, Gelonghui reported that Aidit (301580.SZ) stated at an investor relations event that zirconia material, due to its excellent performance, is currently the preferred material for clinical oral restoration.

Gelonghui FinanceSep 29 02:43 ET